Basic Information
| RNALocate ID: | RLID:01001647 |
| RNA Symbol: | hsa-miR-210-3p |
| Localization: | Cytoplasm |
RNA Information
| RNA Name: | hsa-miR-210 |
| RNA ID: | miRBase:MIMAT0000267 |
| RNA Category: | miRNA |
| Species: | Homo sapiens |
Localization Information
| PubMed ID: | 24918059 |
| Tissue/Cell Line: | Breast adenocarcinoma cells (MCF-7)|Cervical adenocarcinoma cells (HeLa) |
| Method: | Microarray |
| Description: | Data are collected from supplementary Table S2. MiRNA reads in the subcellular fractions. |
Other Subcellular Localization
| RNALocate ID | Localization | Tissue/Cell line | PubMed ID |
| RLID:01001648 | Mitochondrion | Myotube | 27396686 |
| RLID:01001649 | Mitochondrion | Skeletal muscle myoblasts | 21637849 |
| RLID:01001650 | Mitochondrion | Cell line (HEK-293|HeLa) | 22984580 |
| RLID:01001651 | Nucleus | Breast adenocarcinoma cells (MCF-7)|Cervical adenocarcinoma cells (HeLa) | 24918059 |
| RLID:01001652 | Nucleus | Colon adenocarcinoma cells | 20864815 |
| RLID:01001653 | Nucleus | Neural progenitor cells | 21363885 |
| RLID:11001485 | Exosome | Plasma | 19289371 |
| RLID:11001486 | Exosome | Primary dendritic cells|T cell line (J77) | 21505438 |
| RLID:11001487 | Exosome | Breast milk | 22211110 |
| RLID:11001488 | Exosome | Brain tissue | 23382797 |
| RLID:11001489 | Exosome | Plasma | 23663360 |
| RLID:11001490 | Exosome | Human mast cell line (HMC-1) | 24009880 |
| RLID:11001491 | Microvesicle | Seminal plasma | 23539611 |
| RLID:11001492 | Microvesicle | Follicular fluid | 23666971 |
| RLID-D:11000058 | Exosome | B lymphoblastoid cells|Endothelial cells|Epithelial cells|Lymphoma tissue|Mast cells|Tongue tissue | |
| RLID-D:11000328 | Microvesicle | Colon cancer cell line (LIM1863)|Fibroblasts|Mesenchymal stem cells|Urine |
ncRNA Disease Information
| Resource | RNA Symbol | Disease | Link |
| MNDR | hsa-miR-210-3p | Diffuse large b cell lymphoma | MNDR-E-MI-28404 |
| MNDR | hsa-miR-210-3p | Splenic marginal zone lymphoma | MNDR-E-MI-28405 |
| MNDR | hsa-miR-210-3p | Pheochromocytoma | MNDR-E-MI-28406 |
| MNDR | hsa-miR-210-3p | Multiple sclerosis chronic progressive | MNDR-E-MI-28407 |
| MNDR | hsa-miR-210-3p | Peripheral artery disease | MNDR-E-MI-28408 |
| MNDR | hsa-miR-210-3p | Oral squamous cell carcinoma | MNDR-E-MI-28409 |
| MNDR | hsa-miR-210-3p | Large cell neuroendocrine cancer | MNDR-E-MI-28410 |
| MNDR | hsa-miR-210-3p | Follicular lymphoma | MNDR-E-MI-28411 |
| MNDR | hsa-miR-210-3p | Medulloblastoma | MNDR-E-MI-28412 |
| MNDR | hsa-miR-210-3p | High-grade serous ovarian carcinoma | MNDR-E-MI-28413 |
| MNDR | hsa-miR-210-3p | Uterine corpus endometrial carcinoma | MNDR-E-MI-28414 |
| MNDR | hsa-miR-210-3p | Lymphoma non-hodgkin | MNDR-E-MI-28415 |
| MNDR | hsa-miR-210-3p | Estrogen-receptor positive breast cancer | MNDR-E-MI-28416 |
| MNDR | hsa-miR-210-3p | Estrogen-receptor negative breast cancer | MNDR-E-MI-28417 |
| MNDR | hsa-miR-210-3p | Progesterone-receptor positive breast cancer | MNDR-E-MI-28418 |
| MNDR | hsa-miR-210-3p | Progesterone-receptor negative breast cancer | MNDR-E-MI-28419 |
| MNDR | hsa-miR-210-3p | Her2-receptor positive breast cancer | MNDR-E-MI-28420 |
| MNDR | hsa-miR-210-3p | Acute promyelocytic leukemia | MNDR-E-MI-28421 |
| MNDR | hsa-miR-210-3p | Breast cancer luminal | MNDR-E-MI-28422 |
| MNDR | hsa-miR-210-3p | Niemann-pick disease type c | MNDR-E-MI-28423 |
| MNDR | hsa-miR-210-3p | Precursor cell lymphoblastic leukemia-lymphoma | MNDR-E-MI-28424 |
| MNDR | hsa-miR-210-3p | Osteonecrosis | MNDR-E-MI-28425 |
| MNDR | hsa-miR-210-3p | Dermatomyositis | MNDR-E-MI-28426 |
| MNDR | hsa-miR-210-3p | Prostate cancer | MNDR-E-MI-28427 |
| MNDR | hsa-miR-210-3p | Gastric cancer | MNDR-E-MI-28428 |
| MNDR | hsa-miR-210-3p | Gastric lymphoma | MNDR-E-MI-28429 |
| MNDR | hsa-miR-210-3p | Pre-eclampsia | MNDR-E-MI-28430 |
| MNDR | hsa-miR-210-3p | Alzheimer disease | MNDR-E-MI-28431 |
| MNDR | hsa-miR-210-3p | Intracranial aneurysm | MNDR-E-MI-28432 |
| MNDR | hsa-miR-210-3p | Bladder cancer | MNDR-E-MI-28433 |
| MNDR | hsa-miR-210-3p | Esophageal carcinoma | MNDR-E-MI-28434 |
| MNDR | hsa-miR-210-3p | Dysautonomia familial | MNDR-E-MI-28435 |
| MNDR | hsa-miR-210-3p | Head and neck cancer | MNDR-E-MI-28436 |
| MNDR | hsa-miR-210-3p | Graves disease | MNDR-E-MI-28437 |
| MNDR | hsa-miR-210-3p | Leukemia | MNDR-E-MI-28438 |
| MNDR | hsa-miR-210-3p | Cardiovascular disease | MNDR-E-MI-28439 |
| MNDR | hsa-miR-210-3p | Lung cancer | MNDR-E-MI-28440 |
| MNDR | hsa-miR-210-3p | Parkinson disease | MNDR-E-MI-28441 |
| MNDR | hsa-miR-210-3p | Niemann-pick disease | MNDR-E-MI-28442 |
| MNDR | hsa-miR-210-3p | Breast cancer | MNDR-E-MI-28443 |
| MNDR | hsa-miR-210-3p | Pituitary neoplasms | MNDR-E-MI-28444 |
| MNDR | hsa-miR-210-3p | Pancreatic cancer | MNDR-E-MI-28445 |
| MNDR | hsa-miR-210-3p | Melanoma | MNDR-E-MI-28446 |
| MNDR | hsa-miR-210-3p | Atherosclerosis | MNDR-E-MI-28447 |
| MNDR | hsa-miR-210-3p | Hepatitis B | MNDR-E-MI-28448 |
| MNDR | hsa-miR-210-3p | Nephroblastoma | MNDR-E-MI-28449 |
| MNDR | hsa-miR-210-3p | Colon cancer | MNDR-E-MI-28450 |
| MNDR | hsa-miR-210-3p | Ischemic attack transient | MNDR-E-MI-28451 |
| MNDR | hsa-miR-210-3p | Multiple sclerosis relapsing-remitting | MNDR-E-MI-28452 |
| MNDR | hsa-miR-210-3p | Familial ovarian cancer | MNDR-E-MI-28453 |
| MNDR | hsa-miR-210-3p | Prostate adenocarcinoma | MNDR-E-MI-28454 |
| MNDR | hsa-miR-210-3p | Kidney cancer | MNDR-E-MI-28455 |
| MNDR | hsa-miR-210-3p | Carcinoma ductal breast | MNDR-E-MI-28456 |
| MNDR | hsa-miR-210-3p | Balkan nephropathy | MNDR-E-MI-28457 |
| MNDR | hsa-miR-210-3p | Glioblastoma | MNDR-E-MI-28458 |
| MNDR | hsa-miR-210-3p | Astrocytoma | MNDR-E-MI-28459 |
| MNDR | hsa-miR-210-3p | Glioma | MNDR-E-MI-28460 |
| MNDR | hsa-miR-210-3p | Gastrointestinal system cancer | MNDR-E-MI-28461 |
| MNDR | hsa-miR-210-3p | Oligodendroglioma | MNDR-E-MI-28462 |
| MNDR | hsa-miR-210-3p | Nemaline myopathy | MNDR-E-MI-28463 |
| MNDR | hsa-miR-210-3p | Amyotrophic lateral sclerosis | MNDR-E-MI-28464 |
| MNDR | hsa-miR-210-3p | Epilepsy temporal lobe | MNDR-E-MI-28465 |
| MNDR | hsa-miR-210-3p | Osteosarcoma | MNDR-E-MI-28466 |
| MNDR | hsa-miR-210-3p | Breast carcinoma | MNDR-E-MI-28467 |
| MNDR | hsa-miR-210-3p | Pancreatic ductal adenocarcinoma | MNDR-E-MI-28468 |
| MNDR | hsa-miR-210-3p | Cerebral infarction | MNDR-E-MI-28469 |
| MNDR | hsa-miR-210-3p | Meningioma | MNDR-E-MI-28470 |
| MNDR | hsa-miR-210-3p | Uterine cancer | MNDR-E-MI-28471 |
| MNDR | hsa-miR-210-3p | Cervical adenocarcinoma | MNDR-E-MI-28472 |
| MNDR | hsa-miR-210-3p | Gastric adenocarcinoma | MNDR-E-MI-28473 |
| MNDR | hsa-miR-210-3p | Cervical squamous cell carcinoma | MNDR-E-MI-28474 |
| MNDR | hsa-miR-210-3p | Pituitary adenoma | MNDR-E-MI-28475 |
| MNDR | hsa-miR-210-3p | Lung squamous cell carcinoma | MNDR-E-MI-28476 |
| MNDR | hsa-miR-210-3p | Carcinoma lung non-small-cell | MNDR-E-MI-28477 |
| MNDR | hsa-miR-210-3p | Lung adenocarcinoma | MNDR-E-MI-28478 |
| MNDR | hsa-miR-210-3p | Adrenocortical cancer | MNDR-E-MI-28479 |
| MNDR | hsa-miR-210-3p | Thyroid carcinoma | MNDR-E-MI-28480 |
| MNDR | hsa-miR-210-3p | Ovarian carcinoma | MNDR-E-MI-28481 |
| MNDR | hsa-miR-210-3p | Bladder urothelial carcinoma | MNDR-E-MI-28482 |
| MNDR | hsa-miR-210-3p | Pancreatic adenocarcinoma | MNDR-E-MI-28483 |
| MNDR | hsa-miR-210-3p | Myasthenia gravis autoimmune experimental | MNDR-E-MI-28484 |
| MNDR | hsa-miR-210-3p | Kidney renal clear cell carcinoma | MNDR-E-MI-28485 |
| MNDR | hsa-miR-210-3p | Kidney renal papillary cell carcinoma | MNDR-E-MI-28486 |
| MNDR | hsa-miR-210-3p | Clear cell renal cell carcinoma | MNDR-E-MI-28487 |
| MNDR | hsa-miR-210-3p | Large cell carcinoma | MNDR-E-MI-28488 |
| MNDR | hsa-miR-210-3p | Intrahepatic cholangiocarcinoma | MNDR-E-MI-28489 |
| MNDR | hsa-miR-210-3p | Cholangiocarcinoma | MNDR-E-MI-28490 |
| MNDR | hsa-miR-210-3p | Esophageal cancer | MNDR-E-MI-28491 |
| MNDR | hsa-miR-210-3p | Liver cirrhosis | MNDR-E-MI-28492 |
| MNDR | hsa-miR-210-3p | Lung small cell carcinoma | MNDR-E-MI-28493 |
| MNDR | hsa-miR-210-3p | Head and neck squamous cell carcinoma | MNDR-E-MI-28494 |
| MNDR | hsa-miR-210-3p | Myocardial infarction | MNDR-E-MI-28495 |
| MNDR | hsa-miR-210-3p | Encephalomyelitis | MNDR-E-MI-28496 |
| MNDR | hsa-miR-210-3p | Pulmonary hypertension | MNDR-E-MI-28497 |
| MNDR | hsa-miR-210-3p | Breast invasive carcinoma | MNDR-E-MI-28498 |
| MNDR | hsa-miR-210-3p | Early hepatocellular carcinoma | MNDR-E-MI-28499 |
| MNDR | hsa-miR-210-3p | Familiar ovarian carcinoma | MNDR-E-MI-28500 |
| MNDR | hsa-miR-210-3p | B-cell lymphoma | MNDR-E-MI-28501 |
| MNDR | hsa-miR-210-3p | Rheumatoid arthritis | MNDR-E-MI-28502 |
| MNDR | hsa-miR-210-3p | Malignant pleural mesothelioma | MNDR-E-MI-28503 |
| MNDR | hsa-miR-210-3p | Retinoblastoma | MNDR-E-MI-28504 |
| MNDR | hsa-miR-210-3p | Burkitt lymphoma | MNDR-E-MI-28505 |
| MNDR | hsa-miR-210-3p | Acute myelogenous leukemia | MNDR-E-MI-28506 |
| MNDR | hsa-miR-210-3p | Colorectal cancer | MNDR-E-MI-28507 |
| MNDR | hsa-miR-210-3p | Multiple myeloma | MNDR-E-MI-28508 |
| MNDR | hsa-miR-210-3p | Esophageal squamous cell carcinoma | MNDR-E-MI-28509 |
| MNDR | hsa-miR-210-3p | Ependymoma | MNDR-E-MI-28510 |
| MNDR | hsa-miR-210-3p | Polymyositis | MNDR-E-MI-28511 |
| MNDR | hsa-miR-210-3p | Subarachnoid hemorrhage traumatic | MNDR-E-MI-28512 |
| MNDR | hsa-miR-210-3p | Brain injury chronic | MNDR-E-MI-28513 |
| MNDR | hsa-miR-210-3p | Gallstones | MNDR-E-MI-28514 |
| MNDR | hsa-miR-210-3p | Stroke lacunar | MNDR-E-MI-28515 |
| MNDR | hsa-miR-210-3p | Breast cancer her3+ negative | MNDR-E-MI-28516 |
| MNDR | hsa-miR-210-3p | Duke C | MNDR-E-MI-28517 |
| MNDR | hsa-miR-210-3p | High grade dysplastic nodule | MNDR-E-MI-28518 |
| MNDR | hsa-miR-210-3p | Laryngocarcinoma cancer | MNDR-E-MI-28519 |
| MNDR | hsa-miR-210-3p | Solid-pseudopapillary neoplasm of pancreas | MNDR-E-MI-28520 |
RNA Interaction Information
| Resource | RNA Symbol | Species | Link | RNALocate ID |
| RNAInter | ABCB9 | Homo sapiens | RR00023200 |
TOP